CHIEF MEDICAL OFFICER
Fri, Jan 2, 2026
Jan 2
exercised or converted securities in ACLX
13,021 shares @ $0.00
Increased holdings by +2192.10%
Net across this filing: -14.20% (-6,131 shares)
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
ACLXArcellx, Inc.
Health CareBiotechnology